TrialHepatology (Baltimore, Md.)2016

Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY-3+).

Vincent Leroy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.